CaligorRx, Inc.   Report issue

For profit Phase 3
Founded: New York NY United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

CaligorRx, Inc. | Coghlan Group | Coghlan Group (Plasma Sample Supplies) | The Coghlan Group (Plasma Sample Supplies)

Active Ingredients

Drugs in Phase 3 Trials (1)

fospropofol (lusedra) (2 trials)

Drugs in Other Trials (1)

volanesorsen sodium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Polyps (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2